605186.SH
健麾信息
SSE · Healthcare · Medical - Specialties · CN
CNY 25.60
−2.74%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 344.4M | 345.5M | 318.3M | 307.6M | 322.4M |
| Cost of Revenue | 197.0M | 194.6M | 193.9M | 139.0M | 130.3M |
| Gross Profit | 147.5M | 150.9M | 124.5M | 168.6M | 192.1M |
| Operating Expenses | |||||
| R&D Expense | 21.3M | 21.7M | 21.1M | 23.4M | 22.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 48.9M | 46.0M | 43.0M | 30.2M | 18.7M |
| Selling & Marketing Expense | 27.2M | 24.0M | 27.0M | 25.3M | 24.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 106.4M | 100.7M | 98.0M | 79.7M | 64.7M |
| Cost and Expenses | 303.3M | 295.2M | 291.9M | 218.7M | 195.0M |
| Operating Income (EBIT) | 31.3M | 31.5M | 37.3M | 67.6M | 132.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 31.3M | 31.5M | 36.7M | 67.8M | 132.0M |
| Income Tax Expense | 5.9M | 5.8M | 4.1M | 5.9M | 12.1M |
| Bottom Line | |||||
| Net Income | 30.8M | 30.8M | 32.5M | 60.0M | 115.7M |
| Earnings from Cont. Ops | 25.4M | 25.7M | 32.6M | 62.0M | 120.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 30.8M | 30.8M | 32.5M | 60.0M | 115.7M |
| Per Share | |||||
| Basic EPS | CN¥0.23 | CN¥0.23 | CN¥0.24 | CN¥0.44 | CN¥0.85 |
| Diluted EPS | CN¥0.23 | CN¥0.23 | CN¥0.24 | CN¥0.44 | CN¥0.85 |
| Revenue Per Share | CN¥3.03 | CN¥2.58 | CN¥2.35 | CN¥2.26 | CN¥2.37 |
| Shares | |||||
| Basic Shares Outstanding | 113.8M | 133.8M | 135.5M | 136.4M | 136.1M |
| Diluted Shares Outstanding | 113.8M | 133.8M | 135.5M | 136.4M | 136.1M |
| Profitability Metrics | |||||
| EBITDA | — | 57.1M | 60.4M | 73.4M | 135.6M |
| D&A | — | 25.5M | 23.2M | 5.7M | 3.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026